These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 361046)

  • 21. Highly purified cytochrome P-448 and P=450 from rat liver microsomes.
    Ryan D; Lu YH; Kawalek J; West SB; Levin L
    Biochem Biophys Res Commun; 1975 Jun; 64(4):1134-41. PubMed ID: 1137591
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of superoxide in the N-oxidation of N-(2-methyl-1-phenyl-2-propyl)hydroxylamine by the rat liver cytochrome P-450 system.
    Duncan JD; Di Stefano EW; Miwa GT; Cho AK
    Biochemistry; 1985 Jul; 24(15):4155-61. PubMed ID: 2996591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nature of the "455 nm absorbing complex" formed during the cytochrome P450 dependent oxidative metabolism of amphetamine.
    Mansuy D; Beaune P; Chottard JC; Bartoli JF; Gans P
    Biochem Pharmacol; 1976 Mar; 25(5):609-12. PubMed ID: 942497
    [No Abstract]   [Full Text] [Related]  

  • 24. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
    Duescher RJ; Elfarra AA
    Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
    Yamazaki H; Ueng YF; Shimada T; Guengerich FP
    Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans.
    Kashiyama E; Yokoi T; Odomi M; Funae Y; Inoue K; Kamataki T
    Drug Metab Dispos; 1997 Jun; 25(6):716-24. PubMed ID: 9193873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry. Glimpsing the critical intermediate in cytochrome P450 oxidations.
    Sligar SG
    Science; 2010 Nov; 330(6006):924-5. PubMed ID: 21071657
    [No Abstract]   [Full Text] [Related]  

  • 28. The recognition of a soluble cytochrome P450 in rat liver.
    Hasegawa T
    FEBS Lett; 1983 May; 155(2):257-62. PubMed ID: 6852235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine.
    Murray M
    Biochem Pharmacol; 1992 Sep; 44(6):1219-22. PubMed ID: 1417944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of Cytochrome P450 Enzyme Induction and Inhibition in Human Hepatoma Cells.
    Rodrigues RM; De Kock J; Doktorova TY; Rogiers V; Vanhaecke T
    Methods Mol Biol; 2015; 1250():279-85. PubMed ID: 26272150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical studies on cytochrome P-450 solubilized from liver microsomes: partial purification and mechanism of catalysis.
    Coon MJ; Hoeven TA; Kaschnitz RM; Strobel HW
    Ann N Y Acad Sci; 1973; 212():449-57. PubMed ID: 4155931
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
    Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 34. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalytic activity and stereoselectivity of purified forms of rabbit liver microsomal cytochrome P-450 in the oxygenation of the (-) and (+) enantiomers of trans-7,8-dihydroxy-7,8-dihydrobenzo[alpha]pyrene.
    Deutsch J; Vatsis KP; Coon MJ; Leutz JC; Gelboin HV
    Mol Pharmacol; 1979 Nov; 16(3):1011-8. PubMed ID: 119154
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzymatic hydroxylations with molecular oxygen.
    Ullrich V
    Angew Chem Int Ed Engl; 1972 Aug; 11(8):701-12. PubMed ID: 4628360
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polybrominated biphenyls: inducers of hepatic microsomal enzymes and type A cytochrome P450 in the rat.
    Babish JG; Stoewsand GS
    J Toxicol Environ Health; 1977 Nov; 3(4):673-82. PubMed ID: 201767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.